Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Biomech ; 46(5): 890-8, 2013 Mar 15.
Artigo em Inglês | MEDLINE | ID: mdl-23357697

RESUMO

The anterior cruciate ligament (ACL) is known to have a poor self-healing ability. In contrast, the medial collateral ligament (MCL) can heal relatively well and restore the joint function. Transforming growth factor-beta1 (TGF-ß1) is considered to be an important chemical mediator in the wound healing of the ligaments. While the role of TGF-ß1-induced expressions of the lysyl oxidases (LOXs) and matrix metalloproteinases (MMPs), which respectively facilitate the extracellular matrix (ECM) repair and degradation, is poorly understood. In this study, we used equibiaxial stretch chamber to mimic mechanical injury of ACL and MCL fibroblasts, and aimed to determine the intrinsic differences between ACL and MCL by characterizing the differential expressions of LOXs and MMPs in response to TGF-ß1 after mechanical injury. By using semi-quantitative PCR, quantitative real-time PCR, western blot and zymography, we found TGF-ß1 induced injured MCL to express more LOXs than injured ACL (up to 1.85-fold in LOX, 2.21-fold in LOXL-1, 1.71-fold in LOXL-2, 2.52-fold in LOXL-3 and 3.32-fold in LOXL-4). Meanwhile, TGF-ß1 induced injured ACL to express more MMPs than injured MCL fibroblasts (up to 2.33-fold in MMP-1, 2.45-fold in MMP-2, 1.89-fold in MMP-3 and 1.50-fold in MMP-12). The further protein results were coincident with the gene expressions above. The different expressions of LOXs and MMPs inferred the intrinsic differences between ACL and MCL, and the intrinsic differences could help to explain their differential healing abilities.


Assuntos
Ligamento Cruzado Anterior , Colagenases/biossíntese , Ligamentos Colaterais , Fibroblastos/enzimologia , Regulação Enzimológica da Expressão Gênica/efeitos dos fármacos , Proteína-Lisina 6-Oxidase/biossíntese , Regeneração , Fator de Crescimento Transformador beta1/farmacologia , Ligamento Cruzado Anterior/enzimologia , Ligamento Cruzado Anterior/patologia , Lesões do Ligamento Cruzado Anterior , Ligamentos Colaterais/enzimologia , Ligamentos Colaterais/lesões , Ligamentos Colaterais/patologia , Matriz Extracelular/enzimologia , Matriz Extracelular/patologia , Feminino , Fibroblastos/patologia , Humanos , Masculino , Fator de Crescimento Transformador beta1/metabolismo
2.
Biochem Biophys Res Commun ; 252(3): 757-63, 1998 Nov 27.
Artigo em Inglês | MEDLINE | ID: mdl-9837780

RESUMO

Wound healing in ligaments is a complex process which leads to functionally impaired scar tissue, even after extended time postinjury. To investigate the potential role of proteinases and inhibitors, as well as potential regulators of their expression, mRNA levels for collagenase, stromelysin, urokinase, PAI-1, and TIMPs 1 to 4 have been assessed by semiquantitative RT-PCR in RNA isolated from rabbit ligaments 3, 6, and 14 weeks postinjury. In addition, mRNA levels for IL-1, TNF, COX-2, and iNOS, potential regulators of proteinase/inhibitor expression, have been assessed. mRNA levels for the proteinases TIMP-1, -2, and -3 and PAI-1 were elevated early in scar tissue, but TIMP-4 mRNA levels exhibited a different pattern. In contrast, mRNA levels for the cytokines iNOS and COX-2 were either unchanged or depressed early after injury. The results indicate that alterations in mRNA levels for proteinases and inhibitors occurring early after injury are likely being influenced by factors other than IL-1, TNF, or products of COX-2 or iNOS.


Assuntos
Ligamentos Colaterais/enzimologia , Ligamentos Colaterais/lesões , Metaloendopeptidases/genética , RNA Mensageiro/metabolismo , Inibidores de Serina Proteinase/genética , Inibidores Teciduais de Metaloproteinases/genética , Cicatrização , Animais , Colagenases/genética , Colagenases/metabolismo , Ciclo-Oxigenase 2 , Citocinas/genética , Citocinas/metabolismo , Feminino , Isoenzimas/genética , Isoenzimas/metabolismo , Metaloproteinase 3 da Matriz/genética , Metaloproteinase 3 da Matriz/metabolismo , Metaloendopeptidases/metabolismo , Óxido Nítrico Sintase/genética , Óxido Nítrico Sintase/metabolismo , Óxido Nítrico Sintase Tipo II , Inibidor 1 de Ativador de Plasminogênio/genética , Inibidor 1 de Ativador de Plasminogênio/metabolismo , Prostaglandina-Endoperóxido Sintases/genética , Prostaglandina-Endoperóxido Sintases/metabolismo , Coelhos , Inibidores de Serina Proteinase/metabolismo , Fatores de Tempo , Inibidores Teciduais de Metaloproteinases/metabolismo , Ativador de Plasminogênio Tipo Uroquinase/genética , Ativador de Plasminogênio Tipo Uroquinase/metabolismo , Cicatrização/genética
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...